The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Otsuka; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Otsuka; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; MSD; Roche; Takeda
 
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
Research Funding - Bristol-Myers Squibb; Celgene; Roche
Safety and efficacy of atezolizumab (atezo) in patients (pts) with autoimmune disease (AID): Subgroup analysis of the TAIL study.
 
Thomas Newsom-Davis
No Relationships to Disclose
 
Belen Rubio Viqueira
Consulting or Advisory Role - Lilly; MSD Oncology; Roche
Travel, Accommodations, Expenses - MSD Oncology; Roche
 
Delvys Rodriguez-Abreu
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Jorge Alatorre-Alexander
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Roche
 
Hans J.M. Smit
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD
 
Jinming Yu
No Relationships to Disclose
 
Konstantinos N. Syrigos
Honoraria - Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche
 
Hina Patel
Stock and Other Ownership Interests - Roche/Genentech
 
Jonathan Tolson
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Andrés Cardona
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Hans Kristian Vollan
Employment - F. Hoffmann LaRoche
Stock and Other Ownership Interests - F. Hoffmann LaRoche
 
Sergio Jobim Azevedo
No Relationships to Disclose
 
Ernest Choy
Honoraria - Abbvie; Lilly; Merck Serono; Novartis; ObsEva; Pfizer; Radialogica; Regeneron; Roche/Genentech; Sanofi; SynAct Pharma
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Lilly; Novartis; Pfizer; Roche/Genentech; Sanofi/Regeneron
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Janssen; Lilly; Novartis; Pfizer; Regeneron; Roche; Sanofi; UCB
Research Funding - Bio-Cancer Treatment International (Inst); Biogen (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Andrea Ardizzoni
No Relationships to Disclose